HopeStage
Back to all studies
Active Not RecruitingNCT07226011

Safety of accelerated high-dose tDCS for depression

About this titleRead the official source — NCT07226011
Device studyAges 18–70United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
CharlestonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 15, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
20
Sponsor
Medical University of South Carolina
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT07226011
Official title
Show the full official title

Accelerated High-Dose tDCS for Depression: An Open-Label Outpatient Pilot Study

Recruitment & locations

Not recruiting

Charleston

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies